Cardona-Palacio A, Palacio-Toro MA, Vélez-Arango I, García CP

Language: Spanish
References: 16
Page: 123-129
PDF size: 415.93 Kb.

ABSTRACT

Pulmonary silicosis is an occupational disease that continues to cause morbidity in the world. Because silica is the most abundant mineral in soil and rock, sources of occupational exposure to inhalation of silica dust are numerous in various industrial sectors. Alternately, pulmonary silicoproteinosis is a very rare acute form of silicosis, which can develop with a shorter latency period compared to silicosis after the first exposure to silica, and is characterized by a rapid deterioration of lung function, without effective response to any treatment. Due to its atypical form of presentation, we report the case of a 58-year-old man, with a history of working in a gold mine.

REFERENCES

1. Ordóñez-Gómez PL, Carrión-Valero F, Monclou-Garzón EL, Saravia-Flores MR. Silicoproteinosispulmonar. Un caso con supervivenciaprolongada. Rev Clin Esp 2013;213:e5-e8.https://doi.org/10.1016/j.rce.2012.07.002.

2. Krefft S, Wolff J, Rose C. Silicosis: An updateand guide for clinicians. Clin Chest Med2020;41:709-722. https://doi.org/10.1016/j.ccm.2020.08.012.

3. Martínez C, Prieto A, García L, Quero A,González S, Casan P. Silicosis, una enfermedadcon presente activo. Arch Bronconeumol2010;46:97-100. https://doi.org/10.1016/j.arbres.2009.07.008.

4. Manglani R, Akbar S, Beasley M, EpelbaumO. A 44-year-old stone worker with progressivedyspnea: lessons from a new twist on an oldfoe. Monaldi Arch Chest Dis 2022. https://doi.org/10.4081/monaldi.2022.2345.

5. Shen HS, Lai YT, Tsai HC, Chang SC. Artificialstone-associated silicosis with concurrentCryptococcus infection. Respirol CaseRep 2021;9:e00765. https://doi.org/10.1002/rcr2.765.

6. Palma M, Morales C, Contreras E, de León J. Silicoproteinosisaguda. Rev Med 2021;160:256-259. https://doi.org/10.36109/rmg.v160i3.380.

7. Buechner HA, Ansari A. Acute silico-proteinosis.A new pathologic variant of acutesilicosis in sandblasters, characterized by histologicfeatures resembling alveolar proteinosis.Dis Chest 1969;55:274-278. https://doi.org/10.1378/chest.55.4.274.

8. Stafford M, Cappa A, Weyant M, Lara A, EllisJ, Jr., Weitzel NS, et al. Treatment of acute silicoproteinosisby whole-lung lavage. SeminCardiothorac Vasc Anesth 2013;17:152-159.https://doi.org/10.1177/1089253213486524.

9. Marchiori E, Souza CA, Barbassa TG, EscuissatoDL, Gasparetto EL, Souza AS. Silicoproteinosis:high-resolution CT findings in 13 patients.AJR Am J Roentgenol 2007;189:1402-1406.https://doi.org/10.2214/ajr.07.2402.

10. Karnak D, Köycü G, Erdemli E, Dizbay SakS, Kagan-Kadıoglu Y. Acute silicoproteinosis:therapy success. Respiration 2011;82:550-551.https://doi.org/10.1159/000329563.

11. Ben-Abraham R, Greenfeld A, RozenmanJ, Ben-Dov I. Pulmonary alveolar proteinosis:step-by-step perioperative care of whole lunglavage procedure. Heart Lung 2002;31:43-49.https://doi.org/10.1067/mhl.2002.119831.

12. Wasserman K, Blank N, Fletcher G. Lung lavage(alveolar washing) in alveolar proteinosis.Am J Med 1968;44:611-617. https://doi.org/10.1016/0002-9343(68)90062-4.

13. Selecky PA, Wasserman K, Benfield JR,Lippmann M. The clinical and physiologicaleffect of whole-lung lavage in pulmonary alveolarproteinosis: a ten-year experience. AnnThorac Surg 1977;24:451-461. https://doi.org/10.1016/s0003-4975(10)63440-6.

14. Rogers RM, Levin DC, Gray BA, Moseley LW,Jr. Physiologic effects of bronchopulmonarylavage in alveolar proteinosis. Am Rev RespirDis 1978;118:255-264.

15. Asamoto H, Kitaichi M, Nishimura K, ItohH, Izumi T. [Primary pulmonary alveolar proteinosis--clinical observation of 68 patients inJapan]. Nihon Kyobu Shikkan Gakkai Zasshi1995;33:835-845.

16. Abdelmalak BB, Khanna AK, Culver DA, PopovichMJ. Therapeutic whole-lung lavagefor pulmonary alveolar proteinosis: A proceduralupdate. J Bronchology Interv Pulmonol2015;22:251-258. https://doi.org/10.1097/lbr.0000000000000180.